Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin

US9012151B2 · kind B2 · utility

Assignee

• B.R.A.H.M.S GMBH · DE

Inventors

• Leong Ng · Leicester, GB
• Andreas Bergmann · Berlin, DE
• Joachim Struck · Berlin, DE
• Nils Morgenthaler · Berlin, DE
• Jana Papassotiriou · Berlin, DE

Key dates

• Filing date: Nov 8, 2007
• Grant date: Apr 21, 2015
• Expiry date: May 5, 2030

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/50
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention provides methods for the diagnosis and risk stratification of adverse events in post-myocardial infarction patients by means of proADM, whereby a determination of the marker pro-adrenomedullin or partial sequence or a fragment thereof or contained in a marker combination (panel, cluster) is carried out on a post-myocardial infarction patient. The invention also provides a diagnostic device and a kit for the performance of the method of the method of the invention.